Ruplizumab ( 卢利珠单抗 )

产品名称：Ruplizumab ( 卢利珠单抗 )；

产品编号：YR1017；

分子名称：Ruplizumab；

克隆性：Monoclonal；

产品别称：BG-9588, hu5c8, Ruplizumab；

关键词：Ruplizumab, 220651-94-5, BG9588, hu5c8, CD40LG, CD40 ligand, HIGM1, IMD3, TNFSF5, tumor necrosis factor (ligand) superfamily, member 5 (hyper IgM syndrome), CD40 antigen ligand, CD40L, CD154, gp39, hCD40L, hyper IgM syndrome, BG-9588, hu5c8, Ruplizumab, 220651-94-5, BG9588, hu5c8, CD40LG, CD40 ligand, HIGM1, IMD3, TNFSF5, tumor necrosis factor (ligand) superfamily, member 5 (hyper IgM syndrome), CD40 antigen ligand, CD40L, CD154, gp39, hCD40L, hyper IgM syndrome, , 卢利珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG1 Kappa；

宿主：；

CAS号：220651-94-5；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：145448.00 Da；

产品背景：Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia.；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：IF, IP, Neut, FuncS, ELISA, FC；